Validation and use of a new model to maximise the utility of liver allografts.

被引：0
|
作者：
Haydon, GH
Hiltunen, Y
Lucey, MR
Rein, V
Chin, T
Nightingale, PG
Gunson, B
Murphy, N
Neuberger, J
机构：
[1] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England
[2] Raahe Inst Comp Engn & Business, Raahe, Finland
[3] Univ Wisconsin, Madison, WI 53706 USA
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
450
引用
收藏
页码：378A / 378A
页数：1
相关论文
共 50 条
  • [41] Donor specific and non-specific cellular immune responses are enhanced by regeneration of small-for-size liver allografts.
    Omura, T
    Ascher, NL
    Emond, JC
    HEPATOLOGY, 1996, 24 (04) : 1228 - 1228
  • [42] Extended donor criteria liver allografts maximize donor utility and access to transplantation
    Lo, Irene J.
    Kim, Cindy
    Alkofer, Barbara
    Guarrera, James V.
    Samstein, Benjamin
    Ratner, Lloyd
    Jan, Dominique
    Bellemare, Sarah
    Kinkhabwala, Milan
    Emond, Jean C.
    Renz, John F.
    GASTROENTEROLOGY, 2007, 132 (04) : A755 - A755
  • [43] De Novo Use of Everolimus (EVR) in Recipients of Human Leukocyte Antigen (HLA) Identical Living Donor (LD) Allografts.
    Ferreia, A.
    Felipe, C.
    Gusukuma, L.
    Cristelli, M.
    Ueno, P.
    Hannun, P.
    Bessa, A.
    Tedesco, H.
    Medina-Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 145 - 145
  • [44] Short- and long-term outcome of orthotopic liver transplantation using hepatitis C virus-infected allografts.
    Vasta, F
    Fung, JJ
    Eghtesad, B
    Blisard, D
    Demetris, AJ
    Cacciarelli, TV
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 517 - 517
  • [45] De Novo Use of Everolimus (EVR) in Recipients of Human Leukocyte Antigen (HLA) Identical Living Donor (LD) Allografts.
    Ferreia, A.
    Felipe, C.
    Gusukuma, L.
    Cristelli, M.
    Ueno, P.
    Hannun, P.
    Bessa, A.
    Tedesco, H.
    Medina-Pestana, J.
    TRANSPLANTATION, 2014, 98 : 145 - 145
  • [46] A NEW THRESHOLD FOR THE UTILIZATION OF STEATOTIC ALLOGRAFTS IN LIVER TRANSPLANTATION
    Steggerda, Justin
    Noureddin, Mazen
    Kim, Irene
    Brennan, Todd V.
    Todo, Tsuyoshi
    Klein, Andrew S.
    Bloom, Matthew
    HEPATOLOGY, 2019, 70 : 114A - 115A
  • [47] Extended donor criteria allografts maximize donor utility and patient access to liver transplantation
    Kin, C
    Renz, J
    Brown, R
    Emond, J
    GASTROENTEROLOGY, 2005, 128 (04) : A689 - A690
  • [48] EXPRESSION OF THREE ALLOGENEIC MHC CLASS I IN RECIPIENT LIVER SIGNIFICANTLY PROLONGS SURVIVAL OF FULLY-ALLOGENEIC VASCULARISED CARDIAC ALLOGRAFTS.
    Moawadh, Mamdoh
    Paul, Moumita
    Cunningham, Eithne C.
    Wang, Chuanmin
    Tay, Szun S.
    Cunningham, Sharon C.
    Logan, Grant L.
    Alexander, Ian E.
    Bertalino, Patrick J.
    Bowen, David G.
    Bishop, Alex G.
    Sharland, Alexandra F.
    TRANSPLANTATION, 2015, 99 (11) : S6 - S6
  • [49] Recurrent hepatitis B (HB), hepatitis C (HC), and combined hepatitis B&C (HB&C) in liver allografts.
    Anand, N
    Loda, M
    Gordon, F
    Lewis, D
    Khettry, U
    MODERN PATHOLOGY, 1998, 11 (01) : 150A - 150A
  • [50] Development and validation of new model for microvascular transplantation of epiphyseal plate allografts with minimal adjoining epiphyseal and metaphyseal bone
    Bray, PW
    Neligan, PC
    Bowen, CVA
    Danska, JS
    Boyer, MI
    MICROSURGERY, 2003, 23 (02) : 153 - 163
12345